Clinical Trial Update: A Clinical Trial for an Evaluation of Choline Alfoscerate and Donepezil for Cognitive Improvements of Patients With Cerebrovascular Injury in Alzheimer Patients [Phase 4]

View source ↗

Summary

This document provides an update on a Phase 4 clinical trial evaluating choline alfoscerate in combination with donepezil for cognitive improvement in Alzheimer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Choline alfoscerate (choline alfoscerate)
• Donepezil (donepezil)

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Alzheimer Disease | Phase 4 | Status: UNKNOWN